Most Active Peer Reviewers Honored

The “Sentinels of Science” award recognizes especially productive peer reviewers.

By | September 26, 2016


To close out Peer Review Week 2016, a cross-disciplinary celebration of the often-unappreciated work of reviewers, the website Publons on Friday (September 23) announced “Sentinels of Science,” awarding prizes to reviewers and editors who have contributed to the most manuscripts in the past year, as well as an honorary “Sentinel Badge” to the top 10 percent of reviewers in a variety of fields.

The award for most prolific reviewer this year went to Jonas Ranstam, a Swedish medical statistician who reviewed an astonishing 661 papers in the last 12 months—almost two per day. In second place was Grigorios Kyriakopoulos of the National Technical University of Athens, with 437 reviews in the same period. In third place was Columbia University’s Gaetano Santulli, who reviewed 356 manuscripts last year.

“I think we all know how important peer review is,” said Nobel Laureate Richard J. Roberts in a press video from Publons, “and yet, peer reviewers almost never get recognized for the valuable work that they do. Yet without it, science would not be anything like as good as it is.”

Ranstam, a retired professor at Lund University who now works as an independent statistician, says he finds the work rewarding in its own right, with or without a prize. “I often work in the evening and usually on Saturdays, but this is a structure that suits me and my wife. My salary is lower, but my quality of life much higher,” he told STAT News

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: mightythor


Posts: 83

September 26, 2016

What about QUALITY of peer review?

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials